CAJ | 학술논문

产后出血是产妇分娩期的严重并发症，居我国孕产妇死亡原因的首位。本文对产后出血患者100例的临床资料进行了分析、总结，结论显示：欣母沛治疗宫缩乏力性产后出血具有高效、迅速、安全的优点，但也存在一定比例的不良反应，一般时间较短，无需特殊处理。所以，为了确保产妇的安全，对子宫收缩乏力性产后出血产妇应尽早应用欣母沛。
산후출혈시산부분면기적엄중병발증，거아국잉산부사망원인적수위。본문대산후출혈환자100례적림상자료진행료분석、총결，결론현시：흔모패치료궁축핍력성산후출혈구유고효、신속、안전적우점，단야존재일정비례적불량반응，일반시간교단，무수특수처리。소이，위료학보산부적안전，대자궁수축핍력성산후출혈산부응진조응용흔모패。
Postpartum hemorrhage is a serious complication of childbirth, ranking first in the cause of maternal mortality. Clinical data of 100 patients were analyzed, summarized in this article, in conclusion: The hemabate has the efficient, rapid, safe advantage on treating uterine atony postpartum hemorrhage, but there are a certain percentage of adverse reactions, generally shorter, no special treatment. Thus, in order to ensure the safety of women, hemabate should apply as soon as possible for uterine atony postpartum hemorrhage maternal.